PresentationDavid KirnCo-Founder, CEO & Director All right. Thank you very much. I'm Dave Kirn, sometimes the R and N merge and it looks like Kim, so I get that a lot. So David Kirn, good to see you. Co-Founder and CEO of 4D, and Chris Simms and I will be tag-teaming this. Chris is our Chief Commercial Officer. So this is 4D Molecular Therapeutics at a glance. We're developing an adaptable genetic medicines portfolio, including a focus on ophthalmology and pulmonology. Our lead asset, 4D-150 is a potential ...